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Abstract Increasing numbers of people approaching and liv-
ing with end-stage renal disease and failure of the supply of
transplantable kidneys to keep pace has created an urgent need
for alternative sources of new organs. One possibility is tissue
engineering of new organs from stem cells. Adult kidneys are
arguably too large and anatomically complex for direct con-
struction, but engineering immature kidneys, transplanting
them, and allowing them to mature within the host may be
more feasible. In this review, we describe a technique that
begins with a suspension of renogenic stem cells and pro-
motes these cells’ self-organization into organ rudiments very
similar to foetal kidneys, with a collecting duct tree, nephrons,
corticomedullary zonation and extended loops of Henle. The
engineered rudiments vascularize when transplanted to appro-
priate vessel-rich sites in bird eggs or adult animals, and show
preliminary evidence for physiological function. We hope that
this approach might one day be the basis of a clinically useful
technique for renal replacement therapy.
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Clinical need for renal tissue engineering
Renal disease is a serious and increasing problem all over the
developed world. A combination of congenital kidney dis-
eases, acute chemical damage (including pharmacological),
infection and damage from chronic diseases such as diabetes
and idiopathic hypertension mean that a large number of
people reach end-stage renal disease (ESRD) [1]. Two com-
mon treatments exist: dialysis to maintain life and, for more
fortunate patients, transplantation of a functional kidney.
There is, however, a serious shortage of transplantable kid-
neys: the waiting list is around 7,000 people in the UK alone.
This creates an urgent need for new developments in
preventing renal damage in the first place, in regenerating
damaged kidney tissue in situ and in engineering new trans-
plantable kidneys when endogenous kidney function cannot
be saved. This review focuses on the last of these needs.
A full-scale adult kidney is an anatomically complicated
structure that contains >60 cell types [2]. Engineering a new
one is therefore unlikely to be easy. Different research groups
currently take one of three broad approaches: (1) direct con-
struction by printing, (2) repopulation of decellularised matrix
and (3) construction of simple kidney progenitors intended to
mature in a host. So far, although the idea of printing a kidney
has been talked about within the research community and in
more public platforms [3], the spatial resolution and cellular
complexity required is beyond existing technologies. Repop-
ulating a decellularised matrix is more promising. It still
requires a decellularised donor kidney, but in a postmortem
condition, this could be far worse than the minimum required
for living transplant. It also requires a source of adult kidney
cells to perform the repopulation, so is not exactly a solution to
transplant waiting lists, although conceivably a patient’s own
remaining cells from a damaged kidney may be persuaded to
multiply enough to colonize the matrix of a good one. So far,
the best experiments with decellularisation have succeeded in at
least limited repopulation and better filtration than achieved by
decellularised matrix alone [4]. There is still a long way to go
from here to acceptable functionality.
The idea of using stem cells to engineer ‘foetal kidneys’
that can be grafted into a host to grow and mature in situ is the
only one of these approaches that needs neither cells nor
matrix from an adult kidney. Therefore, it might in principle
be a way of escaping the restrictions of waiting lists. This
method, too, has a very long way to go before it is clinically
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practical, but this approach is the subject of the rest of this
review.
Overview of the engineering-then-maturation approach
There are essentially three steps to the ‘engineering-then-
maturation’ approach (Fig. 1). The first is to generate
renogenic (kidney-producing) stem cells from a patient’s
own induced pluripotent stem cells (iPS) cells or some other
convenient stem cell source. The second is to engineer a foetal
kidney from the simple suspension of stem cells that would be
obtained from cultures. The third is to graft the engineered
rudiment in a way that promotes its maturation and function.
Each of these stages presents quite different problems and
requires a different set of skills.
The first problem, that of differentiating embryonic (ES) or
iPS cells into renogenic stem cells is often called reprogram-
ming, although the term is poorly chosen because the aim is
not to alter the natural developmental programme in the
genome, but, rather to move cells to the kidney-producing
part of it. Several groups have made progress with this: One
approach uses specific exogenous growth factors to mimic the
succession of signals that cells would receive in their progress
from inner cell mass via mesoderm and intermediate meso-
derm to metanephrogenic mesoderm or ureteric bud [5]. An-
other approach uses culture in a niche. A third approach works
by directly transfecting the cells with appropriate transcription
factors [6]. Each of these approaches remains a work in
progress, but production of stem cells with some apparently
renogenic characteristics has been achieved, albeit with low
efficiency [6, 7].
Evenwhen the problem ofmaking renogenic stem cells has
been solved, a culture of stem cells is not a kidney. A critical
step is therefore the development of a technique that enables
tissue engineering a small, properly organised kidney. Our
work has been directed towards this step, and a technique
for performing it is the main focus of the rest of this review.
Before discussing this specific step in detail, however, it is
worth considering the feasibility of ‘downstream’ techniques
for transplantation of the engineered foetal kidneys into adult
hosts. Experiments on grafting embryonic kidneys into adults
began in the 1940s and included grafting to the omentum [8],
into the eye [9, 10] and subcutaneously [11]. In rats, E15 foetal
kidneys transplanted into uninephrectomised or pregnant
adult hosts grew and became vascularised; between 17 and
21 days later, it was possible to connect their ureters to that of
the host [12]. As these foetal kidneys continued to mature,
they produced urine, although with only about 6 % of normal
glomerular filtration rate [13]: for comparison, haemodialysis
of humans provides the equivalent of about 10 % normal
filtration rate. If the remaining adult kidney was removed,
the transplants functioned well enough to produce a modest
prolongation of host life—not enough to be clinically useful,
but perhaps enough to indicate that these existing experiments
provide a foundation on which better techniques might be
constructed [13].
The hope of the engineering-then-maturation approach is
that the three critical steps, each currently being tackled almost
in isolation from the other two, can be refined and then
connected to complete a pathway from stem cells to function-
al, transplanted, engineered rudiment.
Development of a renal tissue engineering technique:
the stem cell reaggregation approach
Embryonic kidneys develop almost autonomously: even
when removed from the rest of the embryo and cultured in
simple media, intact organ rudiments will develop essentially
organotypically (except for a lack of blood vessels) to produce
nephrons arranged around and connected to a branched
collecting duct system [14, 15]. When first isolated from the
embryo, the organ rudiments consist of two stem cell types—
ureteric bud and metanephrogenic mesenchyme—which will
each later produce further cell types. Clearly, these cells and
the communication loops between them [16] are capable of
sufficient adaptive self-organisation [17] to arrange them-
Fig. 1 Overview of the engineering-then-maturation approach. Step 1 is
the production of renogenic stem cells from induced pluripotent stem cells
(iPS) cells (or any other stem cell easily obtainable from a patient). Step 2,
the main topic of this review, is the construction of an engineered foetal
kidney from these stem cells. Step 3 is transplantation of the engineered
rudiment and subsequent maturation to physiological maturity in the host
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selves into a foetal organ without detailed external signals and
even tomake an appropriately unusually shaped organ to fit an
unusually constrained environment. A trivial example of this
plasticity, familiar to many in the field, is the ability of kidneys
to grow flat on a filter instead of three-dimensionally in an
embryo. Coming from a research background with a theoret-
ical interest in self-organising systems, we reasoned from
known communication loops that the self-organising ability
of the cells may be sufficiently high to work even when their
original anatomical relationships have been erased. This is the
abstract basis of the stem cell reaggregation approach.
Because there is so far no reliable way of producing sig-
nificant numbers of renogenic stem cells as pure populations
from ES, iPS or mesenchymal stem cells (MSCs), we began
by harvesting E10.5 mouse kidneys and dissociating them
into simple cell suspensions. These suspensions are a simula-
tion of what we hopewill, one day, be available from a reliable
iPS-to-renogenic stem cell process: it has never been our
intention to engineer human kidneys for clinical use from
suspensions of human fetal cells for obvious ethical reasons.
Simply bringing suspensions of mixed ureteric bud and
metanephrogenic mesenchymal cells together by centrifuging
them into a random aggregate does not result in development
of renal structures: instead, the cells die. This cell death is not
surprising: suspending the cells removes them from their
natural cell–cell and cell–matrix contacts. In general, when
untransformed cells lose these contacts, they die by a type of
programmed cell death called anoikis [18], probably a valu-
able safety mechanism for eliminating cells that are errone-
ously placed during natural development. A quite different
line of research in the laboratory, on the role of the cytoskel-
eton in ureteric bud branching [19], indicated that inhibiting
the rho-dependent-kinase (ROCK) strongly inhibited elective
cell death that is a normal feature of metanephric development
[20]. Incubation of reaggregated suspensions of renogenic
stem cells with ROCK-inhibiting drugs suppressed anoikis
and promoted survival but interfered dramatically with subse-
quent morphogenesis, as might be expected from the effects of
ROCK inhibition on intact kidneys [19]. An improved tech-
nique, which used ROCK-inhibiting drugs to protect reaggre-
gates for their first 24 h and then replaced them with simple
media, was much more successful [21]. Over the next few
days, the reaggregates formed many small, branching ureteric
bud tree-lets, which induced early nephron formation in the
surrounding mesenchyme. By morphology and gene expres-
sion, the development of these nephrons was normal, and they
connected to the ureteric bud tree-lets (Fig. 2a).
Arranging the kidney around one collecting duct system
The problem with the simple reaggregation system described
above is that it produces many small collecting duct tree-lets
rather than a single connected tree that could be joined to a
ureter. Clearly, a kidney made in this way, even if it could be
connected to the blood system, would not be useful because
the filtrate would have nowhere to go. Also, at a more subtle
level, there would be no clear corticomedullary organisation.
Formation of multiple small collecting duct tree-lets is inher-
ent in the manner in which the system is assumed to work, as
ureteric bud cells aggregate together to make multiple small
clumps that cannot be expected to join because growing
ureteric bud branches show mutual repulsion (Davies et al.,
unpublished data).
A method by which to engineer kidneys arranged around a
single collecting duct system was developed by us [22] using
a serial culture method. The first step is a basic reaggregation
culture to produce a ‘kidney’ with many small ureteric bud
Fig. 2 Engineered renal tissues produced by single (left panel) and serial
(right panel) reaggregation. Each contains nephrons (n: red) and collecting
ducts (cd: green); in the single reaggregation system, the organ is
disorganised because there are many collecting duct tree-lets rather than
one tree. The serial reaggregation system generates a kidney organised
around a single collecting duct tree. These micrographs are ‘spare’ images
from data sets described in our earlier publications [21, 22]
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tree-lets, as above. One of these is then isolated and surrounded
by a fresh suspension of metanephrogenic mesenchymal cells.
The result is ramification of the tree-let into a single collecting
duct tree and conversion of metanephrogenic mesenchymal
cells into cap mesenchyme, nephrons and stroma in the usual
manner, with nephrons connecting to the collecting duct sys-
tem (Fig. 2b). Under appropriate culture conditions that favour
corticomedullary zonation in intact kidney rudiments, these
serial reaggregates show a distinct outer cortex and inner
medulla and medullary extension of loops of Henle [23].
Connecting to a blood supply
Reaggregated kidneys, as with intact kidney rudiments cul-
tured in incubators filled with 5% carbon dioxide (CO2) in air,
show little or no development of a vascular system. This is a
problem for tissue engineering for the purposes of regenera-
tive medicine, the main physiological function of a kidney is
to filter blood: normal adult human kidneys receive about
20 % of cardiac output. Clearly, some way has to be found
to connect the nephrons of engineered kidneys to flowing
blood.
The metanephrogenic mesenchyme of kidney rudiments
contains endogenous endothelial progenitors even though
they do not differentiate well in normal culture. Endothelial
differentiation can be encouraged by incubation in very low
oxygen, but this results in large masses of endothelial cells
rather than organised vessels [24]. If a kidney rudiment is
cultured with an external source of vessels that are capable
of angiogenesis, for example the chorioallantoic membrane
(CAM) of a bird egg, it is capable of attracting exogenous
blood vessel branches and thereby gaining a blood supply [25,
26].When such grafts are made from one strain or species into
another, it is possible to determine that blood vessels are in
fact derived from both graft and host, generally the larger
vessels being host-derived and the smaller ones coming from
the graft’s own mesenchyme [27]. Presumably, the incoming
exogenous vessels somehow stimulate differentiation of en-
dogenous endothelial progenitors, though the biology of this
is not understood.
Whatever the underlying organising mechanisms, the abil-
ity of kidney rudiments to acquire a vascular system when
placed near host vessels offers a possible method for equip-
ping cell-derived reaggregate kidneys with a functional blood
supply. Grafting them on chick CAM (Fig. 3a) results in
ingrowth of host vessels (Fig. 3b) and formation of
glomerulus-type structures in the graft (Fig. 3c).
First functional tests
It has been known for some years that foetal kidneys
transplanted into adult hosts can organise a blood supply,
grow and show some physiological activity [13]. Logically,
if the engineered foetal kidneys really are like their natural
counterparts, they should behave the same way. We adapted
the methods used in foetal kidney transplantations to assess
the ability of engineered reaggregated kidneys to function in a
mammalian host. Integration with the host vasculature hap-
pened efficiently only when the reaggregates were presoaked
in vascular endothelial growth factor (VEGF), a known stim-
ulant of angiogenesis [28]. When VEGF was used, however,
host vessels entered the grafted engineered kidney. Injected
fluorescently labelled albumen crossed from the blood system
to enter the urinary space and was recovered by proximal
tubule cells [29]. On a positive note, this implies that fluid
flow from vessels to urinary space is taking place, presumably
through glomeruli, and that at least some proximal reuptake
function is normal. On the other hand, a well-constructed
glomerulus should not allow major flow of molecules as large
as albumin across it. In the system used, quantitative measure-
ment was not possible, so the physiological quality of the
engineered, grafted kidneys remains unclear with respect to
filtration, recovery or concentration.
Fig. 3 Vascularisation of engineered kidney rudiments on chick chorio-
allantoic membrane (CAM). a The CAM itself. b Chick vessels entering
an engineered kidney rudiment (the dark object, centre). c A section
through such a kidney: present are S-shaped body-stage (SB) nephrons
and more mature nephrons that have Bowman’s capsules with glomeruli
(G) and a lower cleft (LC) consisting of podocytes (Po) and endothelial
cells (En). As in normal nephrons, the distal tubule (DT) approaches the
glomerular entrance, where it makes a macula densa (MD)
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Prospects
From the point of view of tissue engineering with a view to
transplantation, the most pressing needs are to: (1) investigate
how much engineered kidneys can grow and mature after
grafting, (2) establish the physiological parameters of the
engineered kidneys and (3) find a way of obtaining renogenic
stem cells from a patient (for example, by partly differentiat-
ing iPS cells).
Given the similarity between engineered foetal kidneys and
real ones, existing programmes of research and development
on transplantation of foetal kidneys might be expected to
improve the prospects for transplanted kidneys, even if such
programmes are not specifically aimed at doing this. There are
already some encouraging results from transplantation of foe-
tal kidneys to large animals instead of rodents. E28 pig kidney
to adult pig transplants, for example, show growth and pro-
duction of new nephrons while in the host [30, 31]. Likely
areas for development include finding better sites for engraft-
ment, protection of immature kidneys from adult blood pres-
sure (something likely to be a problem in humans, even if it is
not in rodents), and possibly developing ways to engraft many
kidneys into one host so they can share the physiological load.
Identifying humoral changes that take place on unilateral
nephrectomy and during pregnancy, both of which are already
known to encourage growth of grafted kidney rudiments, may
also be useful.
Testing the physiological function of engineered kidneys is
difficult in the context of a mammalian host. It may be better
to return to the chick CAM system, in which the kidney is
plumbed in to a pumped blood supply powered by the chick
embryo heart. This system is highly accessible for injection of
tracer molecules or drugs into the blood supply and to sam-
pling from the collecting duct system. This would allow
measurement of filtration rates, cutoff, concentration of fil-
trate, osmolarity of the medullary stroma etc.
The problem of obtaining renogenic stem cells may turn out
to be themost frustrating, or it may fall quickly. The reaggregate
system offers a highly valuable tool for stem cell biologists
because it provides a clear test for renogenic activity. In partic-
ular, it is possible to mix marked candidate stem cells with the
embryo-derived kidney stem cells and then to test whether they
contribute tomaking a chimeric engineered organ [20, 32]. This
has already been used to test the abilities of some suspected
stem cells with results that are, frankly, disappointing compared
with the abilities of cells straight from the kidney-forming part
of the embryo [33–36]. Any cells that do pass this test would be
highly promising candidates for practical use.
The entire approach of tissue engineering as a means of
restoring renal function will not be helpful in all patients with
ESRD: it will probably be most suited to diseases involving
gradual but unstoppable renal degeneration, which allow time
for maturation of a graft in a still healthy body rather than for
fast-onset, acute failure. Even if it can be made to work as well
as hoped, engineering new organs will probably be just one
technique amongst many, including conventional transplanta-
tion and, hopefully, stem-cell-based regeneration in situ.
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